SCHEMBL8316735

SCHEMBL8316735

O=C(O)C1Cc2c([nH]c3ccccc23)C(c2cccc3ccccc23)N1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.71
TSHR P16473 2/20 0.71
MAPK1 P28482 1/20 0.71
KDM4E B2RXH2 5/20 0.63
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
ALDH1A1 P00352 3/20 0.63
MAPT P10636 1/20 0.63
HPGD P15428 1/20 0.63
HSD17B10 Q99714 2/20 0.60
ALOX15 P16050 1/20 0.60
CYP2C19 P33261 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
ALOX12 P18054 1/20 0.57
PDE5A O76074 4/20 0.56
CCKBR P32239 1/20 0.49
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8320595 0.86 PDE5A (0.77) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL8323007 0.85 CYP2D6 (0.71) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL8325074 0.85 PDE5A (0.76) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL17760580 0.85 CYP2D6 (0.71) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL8316773 0.85 CYP2D6 (0.71) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL8321391 0.85 CYP2D6 (0.71) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL764194 0.83 CYP2D6 (1.00) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL29630317 0.83 CYP2D6 (1.00) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL4787100 0.83 CYP2D6 (1.00) CYP2D6TSHRMAPK1KDM4EMEN1
SCHEMBL17760630 0.83 CYP2D6 (1.00) CYP2D6TSHRMAPK1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004113336-A1 CARBOLINE AND BETACARBOLINE DERIVATIVES FOR USE AS HDAC ENZYME INHIBITORS CHROMA THERAPEUTICS LIMITED (GB) 2004-12-29 WO disclosed